ALIGN TECHNOLOGY, INC. Unrealized Gain (Loss) on Derivatives
ALIGN TECHNOLOGY, INC. (ALGN) reported Unrealized Gain (Loss) on Derivatives of $9.20 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2020-05-05
- ALIGN TECHNOLOGY, INC. unrealized gain (loss) on derivatives for the quarter ending 2020-03-31 was $9.20M.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month |
|---|---|
| 2020-03-31 | $9.20M 10-Q · filed 2020-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |